BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9342442)

  • 1. Similarity between natural and recombinant human alpha-fetoprotein as inhibitors of estrogen-dependent breast cancer growth.
    Bennett JA; Semeniuk DJ; Jacobson HI; Murgita RA
    Breast Cancer Res Treat; 1997 Sep; 45(2):169-79. PubMed ID: 9342442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
    Bennett JA; Zhu S; Pagano-Mirarchi A; Kellom TA; Jacobson HI
    Clin Cancer Res; 1998 Nov; 4(11):2877-84. PubMed ID: 9829755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol.
    Jacobson HI; Bennett JA; Mizejewski GJ
    Cancer Res; 1990 Jan; 50(2):415-20. PubMed ID: 1688512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer.
    Vakharia D; Mizejewski GJ
    Breast Cancer Res Treat; 2000 Sep; 63(1):41-52. PubMed ID: 11079158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scintigraphic detection of breast cancer xenografts with Tc-99m natural and recombinant human alpha-fetoprotein.
    Line BR; Feustel PJ; Festin SM; Andersen TT; Dansereau RN; Lukasiewicz RL; Zhu S; Bennett JA
    Cancer Biother Radiopharm; 1999 Dec; 14(6):485-94. PubMed ID: 10850335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The recombinant third domain of human alpha-fetoprotein retains the antiestrotrophic activity found in the full-length molecule.
    Festin SM; Bennett JA; Fletcher PW; Jacobson HI; Shaye DD; Andersen TT
    Biochim Biophys Acta; 1999 Apr; 1427(2):307-14. PubMed ID: 10216247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer.
    Mesfin FB; Andersen TT; Jacobson HI; Zhu S; Bennett JA
    J Pept Res; 2001 Sep; 58(3):246-56. PubMed ID: 11576331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-fetoprotein-derived antiestrotrophic octapeptide.
    Mesfin FB; Bennett JA; Jacobson HI; Zhu S; Andersen TT
    Biochim Biophys Acta; 2000 Apr; 1501(1):33-43. PubMed ID: 10727847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen.
    Bennett JA; Mesfin FB; Andersen TT; Gierthy JF; Jacobson HI
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2211-5. PubMed ID: 11830647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of the estrogen-activated growth-regulatory forms of alpha-fetoprotein in mouse amniotic fluid.
    Mizejewski GJ; Keenan JF; Setty RP
    Biol Reprod; 1990; 42(5-6):887-98. PubMed ID: 1696509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol-activated alpha-fetoprotein suppresses the uterotropic response to estrogens.
    Mizejewski GJ; Vonnegut M; Jacobson HI
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2733-7. PubMed ID: 6189129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
    Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
    J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer.
    Jordan VC; Gottardis MM; Robinson SP; Friedl A
    J Steroid Biochem; 1989; 34(1-6):169-76. PubMed ID: 2626014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purified human alpha-fetoprotein inhibits follicle-stimulating hormone-stimulated estradiol production by porcine granulosa cells in culture.
    Keel BA; Eddy KB; He Y; Gangrade BK; May JV
    Mol Cell Endocrinol; 1993 Jul; 94(1):21-5. PubMed ID: 7690723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiestrogenic action of toremifene on hormone-dependent, -independent, and heterogeneous breast tumor growth in the athymic mouse.
    Robinson SP; Jordan VC
    Cancer Res; 1989 Apr; 49(7):1758-62. PubMed ID: 2522347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
    Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
    Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and oncogene mediated growth regulation of human breast cancer cells.
    Kasid A; Lippman ME
    J Steroid Biochem; 1987; 27(1-3):465-70. PubMed ID: 3501040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
    Toi M; Bicknell R; Harris AL
    Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK; Hobbs K; Clark GM
    Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen induction of progestophilins in rat estrogen-sensitive cells grown in media supplemented with sera from castrated rats and from rats bearing an alpha-fetoprotein-secreting hepatoma.
    Soto AM; Lee H; Siiteri PK; Murai JT; Sonnenschein C
    Exp Cell Res; 1984 Feb; 150(2):390-9. PubMed ID: 6198194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.